MCKESSON CORP

MCK · NYSE · SIC 5122: Wholesale-Drugs, Proprietaries & Druggists' Sundries · Market Cap: $104.9B · 51,000 employees
221
SEC Filings
$901.77
Close 2026-08-11
2
Transcripts
51,000
Employees

Business Summary

McKesson Corporation, tracing roots to 1833, is a diversified healthcare services company operating four segments: North American Pharmaceutical (distribution of branded, generic, specialty, biosimilar, and OTC drugs in U.S. and Canada), Oncology & Multispecialty (specialty drug distribution, oncology network support, cell and gene therapy), Prescription Technology Solutions (medication access and affordability technology), and Medical-Surgical Solutions (medical-surgical supplies and pharmaceuticals to non-acute settings). McKesson partners with biopharma companies, pharmacies, care providers, and governments.

Latest Stock Quote

MCK 2026-08-11 $901.77 O:$877.33 H:$902.05 L:$877.33 Vol:0.8M VWAP:$896.4186
origin leaf: null

Next Earnings

expected 2026-09-11

Key People

NameRolePeriod
Allen LutzAnalyst, BofA Securities? – present
Brian TanquilutAnalyst, Jefferies LLC? – present
Daniel GrosslightAnalyst, Citigroup Global Markets? – present
Eric PercherAnalyst, Nephron Research LLC? – present
George HillAnalyst, Deutsche Bank Securities? – present
Glen SantangeloAnalyst, Barclays Capital? – present
Kevin CaliendoAnalyst, UBS Securities LLC? – present
Lisa C. GillAnalyst, JPMorgan Securities LLC? – present
Michael ChernyAnalyst, Leerink Partners LLC? – present
Brian Scott TylerChief Executive Officer & Director, McKesson? – present
Britt J. VitaloneExecutive Vice President & Chief Financial Officer, McKesson? – present
Jeni DominguezVice President - Investor Relations, McKesson? – present

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMCKdiscussed Cybersecurity
topic_mentionMCKdiscussed Regulation
topic_mentionMCKdiscussed Healthcare & Bio
topic_mentionMCKdiscussed Artificial Intelligence
topic_mentionMCKdiscussed Cybersecurity
topic_mentionMCKdiscussed Autonomous Vehicles
topic_mentionMCKdiscussed Capital Expenditure
topic_mentionMCKdiscussed Supply Chain
topic_mentionMCKdiscussed Regulation
topic_mentionMCKdiscussed Enterprise
topic_mentionMCKdiscussed Automotive
topic_mentionMCKdiscussed Healthcare & Bio
topic_mentionMCKdiscussed AI Compute
topic_mentionMCKdiscussed Platform & Ecosystem
metricMCK free cash flowreported $9.6 billion
guidanceMCKguided guidance range for interest expense to $215 million
guidanceMCKguided outlook includes plans to repurchase approximately $2.5 billion
outlookMCKstated We anticipate revenue gro wth of 12% to 16% and operating profit growth of 13% to 17%, reflecting our strong third quarter performance and the confidence that we
outlookMCKstated We anticipate revenue to increase 10% to 14% and operating profit to increase 8% to 12%
outlookMCKstated we anticipate continued growth of GLP - 1 medication

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-05-082026-03-310000927653-26-000069EDGAR—
2025-05-092025-03-310000927653-25-000036EDGAR78K words
2024-05-082024-03-310000927653-24-000035EDGAR—
2023-05-092023-03-310000927653-23-000038EDGAR—
2022-05-092022-03-310000927653-22-000051EDGAR—
2021-05-122021-03-310000927653-21-000039EDGAR—
2020-05-222020-03-310000927653-20-000033EDGAR—
2019-05-152019-03-310000927653-19-000009EDGAR—
2018-05-242018-03-310000927653-18-000010EDGAR—
2017-05-222017-03-310000927653-17-000007EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-052026-06-300000927653-26-000234EDGAR—
2026-02-042025-12-310000927653-26-000017EDGAR33K words
2025-11-062025-09-300000927653-25-000140EDGAR—
2025-08-062025-06-300000927653-25-000107EDGAR—
2025-02-062024-12-310000927653-25-000014EDGAR—
2024-11-072024-09-300000927653-24-000125EDGAR—
2024-08-072024-06-300000927653-24-000098EDGAR—
2024-02-082023-12-310000927653-24-000021EDGAR—
2023-11-022023-09-300000927653-23-000083EDGAR—
2023-08-022023-06-300000927653-23-000062EDGAR—
2023-02-022022-12-310000927653-23-000017EDGAR—
2022-11-022022-09-300000927653-22-000097EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-050000927653-26-000232EDGAR—
2026-07-240000927653-26-000215EDGAR—
2026-07-010000927653-26-000185EDGAR—
2026-06-120000927653-26-000167EDGAR—
2026-05-070000927653-26-000066EDGAR—
2026-04-280000927653-26-000053EDGAR—
2026-04-060000927653-26-000045EDGAR165K words
2026-03-060000927653-26-000038EDGAR—
2026-03-050000927653-26-000035EDGAR—
2026-02-040000927653-26-000015EDGAR—

221 total filings indexed. 189 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— MCK Earnings Call Transcript
— MCK Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

CAH — CARDINAL HEALTH INC NASC — Can B Corp HKPD — Cellyan Biotechnology Co., Ltd COR — Cencora, Inc. COSM — Cosmos Health Inc. HLF — HERBALIFE LTD. HWH — HWH International Inc. NUS — NU SKIN ENTERPRISES, INC.

Tags

retail-national-accounts-(national/regional-retail-chains,-mail-order-pharmacies,-mass-merchandisers) community-pharmacy-and-independent-pharmacies institutional-healthcare-providers-(hospitals,-health-systems,-integrated-delivery-networks,-long-term-care) oncology-and-specialty-care medical-surgical-non-acute-settings-(physician-offices,-surgery-centers,-nursing-homes,-hospice,-home-health) biopharma-and-life-sciences canadian-pharmaceutical-distribution government-markets six-sigma-methodology

Company Identity

CIK0000927653
TickerMCK
ExchangeNYSE
SIC5122: Wholesale-Drugs, Proprietaries & Druggists' Sundries
IncorporatedDE
Websitehttps://www.mckesson.com
Listed1987-08-03

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 2ca9a214514e549b919392c0c53eb2165c2c203450986f5a7444e226495f78b4
parent: a1e131b0d9bbcf1e505cb83e1408c7d1109cb5a0c1022a065da666203225a841
content hash: 0a3a30d48f972a3d142819af8d2aab77917acdee8308864fc55483e7be6db6e2
signed: 2026-08-12T19:04:11.572Z
sources: 24 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MCK using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MCK, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MCK (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.